Fourteen years’ clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy

Rotavirus (RV) causes up to half of hospital and community acute gastroenteritis (AGE) cases in young children in Italy. Two RV vaccines, available since 2006, are human RV (HRV) and human bovine RV (HBRV). This report looks back at the implementation of RV vaccination with HRV in Italy, and at HRV...

Полное описание

Библиографические подробности

Главные авторы:	Paolo Bonanni, Giorgio Conforti, Elisabetta Franco, Giovanni Gabutti, Federico Marchetti, Antonella Mattei, Rosa Prato, Giovanni Vitali Rosati, Francesco Vitale
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Taylor & Francis Group 2021-11-01
Серии:	Human Vaccines & Immunotherapeutics
Предметы:	rotavirus italy vaccination epidemiology safety impact
Online-ссылка:	http://dx.doi.org/10.1080/21645515.2021.1955611
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!